Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Kosan’s epothilone drug shows antitumor activity
It also showed signs of activity in patients with non-small cell lung, ovarian, breast, prostate, pancreatic, head and neck and colon cancer, according to Kosan. The Phase I
It also showed signs of activity in patients with non-small cell lung, ovarian, breast, prostate, pancreatic, head and neck and colon cancer, according to Kosan. The Phase I
In a separate suit against Lichtwer Pharma, one of Nutrinova’s customers, a similar judgment was announced. The first suit involves Lonza’s German sale and use of a fatty
Novo Nordisk expects to launch Levemir (insulin detemir) in Japan in its prefilled FlexPen device and in Penfill for its NovoPen injection systems before the end of 2007.
The Japanese Ministry of Health approval means that lung cancer patients in Japan will now have a new treatment option that has been demonstrated to increase overall survival
The estimated value of the combined company is approximately $115 million, based on the closing price of Avant’s stock on October 19, 2007. The all-stock transaction, approved by
Sequella’s lead drug, SQ109, shows excellent in vitro and in vivo activity against drug-susceptible and drug-resistant tuberculosis (TB) bacteria, including XDR-TB, according to the company. Furthermore, SQ109 synergizes
Clinical trials have demonstrated Voltaren Gel to be highly effective in treating osteoarthritis pain in the hands and knees, which are the body’s most commonly affected joints, according
The research effort, which will be centered on tamoxifen, is the latest in a rapidly growing field of studies linking individual genetics to the safety and efficacy of
The US regulatory body has sent Theravance and its partner Astellas Pharma US Inc, affiliate of Tokyo-based Astellas Pharma, an approvable letter indicating that the telavancin application is
SenoRx is partnering with local distributors who have breast imaging and/or interventional radiology franchises in Austria, Belgium, England, Hong Kong, Ireland, Luxembourg, The Netherlands, Singapore, Switzerland and Taiwan.